Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study

NCT: NCT07166133 · RECRUITING

NCT IDNCT07166133
StatusRECRUITING
Start Date2026-03-02
Completion2036-03

Brief Summary

A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.

Frequently Asked Questions

What is GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study?

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study is a clinical trial registered under NCT07166133. Current status: RECRUITING.

What is the status of NCT07166133?

The current status of NCT07166133 (GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study) is: RECRUITING.

When did GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study start?

GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study started on 2026-03-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑